Jeong et al. identify miRNA-124 as a negative regulator of MYC and BCL2 expression in B-cell lymphomas and the genetic inhibition of this miRNA enhanced the fitness of these tumors [30]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.